Caribou Biosciences, Inc. (CRBU) vs Serina Therapeutics, Inc. (SER)

Caribou Biosciences, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and Serina Therapeutics, Inc. are of similar size ($44.2M and $41.9M). Caribou Biosciences, Inc. grew revenue faster over the last twelve months: 1.60% against −94.2%. Serina Therapeutics, Inc. has the higher net margin (0.00% vs −1,085.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Caribou Biosciences, Inc. leads on 9 and Serina Therapeutics, Inc. on 7.

Valuation

Metric CRBU SER Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 126.73 9.40
P/B 0.62 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.45 n/m 0.66
EV/Sales (5.03) 32.54 9.02
Earnings yield (234.09%) (135.00%) (32.88%)
Free cash flow yield (275.02%) (92.42%) (23.13%)

Profitability

Metric CRBU SER Biotechnology median
Gross margin 100.00% 100.00% 68.51%
Operating margin (1,140.55%) 0.00% 0.00%
Net margin (1,085.00%) 0.00% 0.00%
Free cash flow margin (985.95%) 0.00% 0.00%
Return on equity (93.80%) (306.22%) (51.96%)
Return on assets (64.44%) (136.00%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU SER Biotechnology median
Revenue growth (TTM) 1.60% (94.21%) 6.76%
EPS growth (last fiscal year) 3.64% (26.49%) 29.88%
Revenue growth, 5-year CAGR (2.03%) (18.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU SER Biotechnology median
Debt to equity 0.00 0.16 0.00
Current ratio 4.97 6.65 4.97
Net debt to EBITDA 0.96 0.00 1.01

Dividend

Metric CRBU SER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBU SER Biotechnology median
Market cap 44.20m 41.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack